Background The Calman-Hine Report in England and Wales and the Campbell Report in Northern Ireland initiated a major reorganization of cancer services with the aim of improving the provision and delivery of care to cancer patients. In this paper, breast cancer patients diagnosed in 1996 and those diagnosed in 2001 are compared in order to examine the extent of service change in Northern Ireland.
Introduction
Cancer is one of the most common diseases in the United Kingdom; one in three people will develop cancer at some point in their life and one in four will die from it. The delivery of care to cancer patients is an important part of the work of the NHS. A major policy and planning review of cancer services was instigated during the 1990s following a number of factors such as expressions of public and professional concern about the existence of a cancer postcode lottery whereby place of residence determined access to care, potentially affecting the quality of life of patients or their survival. In addition, the patient group Radiotherapy Action Group Exposure (RAGE) exposed deficiencies in radiotherapy. 1 Also, there was mounting evidence that specialization, including centralised treatment, 2,3 entry into clinical trials, 2, 4 clinician workload 5 and surgery by specialists 6 improved quality of care and survival for cancer patients. This evidence together with the comparatively high cancer mortality rate in the United Kingdom 7 led to recommendations for service changes from the Chief Medical Officers in England and Wales (the Calman-Hine Report,1995). 8 The Campbell Report (1996) outlined similar changes for cancer services in Northern Ireland. 9 The main recommendations of the Campbell report were increased specialization in cancer management, a multidisciplinary team approach, enhanced communication between primary and secondary care, enhanced palliative care and integration of cancer services in four geographically positioned cancer units and one cancer centre. Little information is available on how the delivery of cancer care to patients has changed following the publication of the Calman-Hine and the Campbell Reports. This paper presents the results of a population based comparative study of the processes and service changes relating to the reorganization and delivery of breast cancer care between 1996 and 2001.
Methods

Data collection
The Northern Ireland Cancer Registry (NICR) provided a list of all female patients diagnosed with invasive primary breast cancer (ICD-10 codes C50.0-C50.9) in 1996 and in 2001. This list included patients with Paget's disease and patients who had a previous primary of any site or a concurrent primary malignancy of another site. Trained data abstractors examined the medical record of each patient and specific details were extracted using a proforma which was designed in consultation with cancer care professionals. See www.qub.ac.uk/nicr/research for a copy of the proforma.
Data cleaning
The database was subjected to rigorous quality control and consistency checks. For example, consultants names were verified, long delay times were queried and diagnostic methods were cross-checked with details about treatment and investigations. Patients whose diagnosis was based only on a death certificate were excluded as were patients for whom there was insufficient information to permit descriptive analysis.
Data analysis
The number of hospitals performing cancer surgery in each of the 2 years was used as a measure of the centralization of services.
Patients were assigned to the consultant leading the surgical team irrespective of whether the consultant personally performed the surgery or it was performed by another surgeon under his/her supervision. In both 1996 and 2001, consultants were designated as breast cancer specialists if they managed more than 30 breast cancer patients in that year. In addition, in the year 2001, breast specialists were defined using the Department of Health, Social Services and Public Safety's directory of breast cancer specialist teams 10 (No such directory existed in 1996).
Patients were assigned to one of two group categories depending on Oestrogen Receptor (ER) status and hormone therapy. Group 1 included patients who had positive ER status and were prescribed hormone therapy and also patients who were ER negative and not prescribed hormone therapy. Group 2 comprised all other patients.
The British Association of Surgical Oncology Guidelines (BASO) 11 specifies that four axillary nodes should be sampled in breast cancer patients. The American Joint Committee on Cancer (AJCC) 12 Cancer Staging Manual specifies that six axillary nodes should be sampled. Comparisons were made between the proportion of patients in 1996 and 2001 whose axillary surgery met these criteria and then in terms of who received level three axillary clearance (axillary surgery up to the apex of the axilla). Descriptive comparisons (frequencies and percentages) and tests of association (chi-square) and differences (t-tests) at the 5 per cent level of significance were made between the two years and the variables of interest. Missing values were entered as 'NR'. Each test of association was calculated firstly by including 'NR' values and then by excluding them. Percentage figures in the results section are based on the total number of patients including those for whom values are missing.
Results
The results of the comparative analysis are summarised in Table 1 . Data were analysed on 764 patients in 1996 and 881 patients in 2001. There was an increase (by 4 days) in the period of time between referral by GP and being seen for the first time at hospital, but there was no change in median waiting times between being seen at hospital and the date of diagnosis. The number of hospitals at which breast cancer surgery was per- (Table 1) .
Discussion
It is important to note that the results presented here are based on a retrospective note review. However, the data was validated Downloaded from https://academic.oup.com/jpubhealth/article-abstract/27/2/171/1595714 by guest on 14 January 2019 through presentations and discussion with clinicians and other staff working in breast cancer services, all of whom indicated that the data reflected their experience of service delivery and practice. The same methods were employed in each study year and the data abstractors followed specific, standardized instructions regarding the collection and interpretation of data contained within patient notes in an attempt to minimize bias. The study took place in 2002 (after both time periods for which Clearly the level of recording in the notes has improved (e.g. the noting of discussions between consultants and patients).
Better recording in the notes may, in itself, be viewed as a marker of service improvement.
Evidence that specialization improves survival for breast cancer patients has been demonstrated by Gillis and Hole. 6 This study has shown that specialization as defined by those who performed >30 operations in a year improved significantly between 1996 and 2001, further work is required to determine the impact on outcome. 13 The Campbell report and the Calman-Hine report both recommended a team approach to cancer care, which has been shown to improve outcomes. 14 The review of patient charts showed a disappointing lack of change in MDMs. However, subsequent discussions with professionals indicate that MDMs were taking place regularly in 2001 but that they were not being recorded in the patients' notes. The Campbell report also recommended that all patients have early referral to hospital and the BASO guidelines 11 recommended that over 80 per cent of urgent referrals were to be seen within five working days of receipt of the referral letter (assume 7 days from date of referral) and 70 per cent of all other referrals were to be seen within 15 working days. Diagnostic delays should also be kept to a minimum. 15 In this study the average time between first being seen at hospital and diagnosis fell significantly between 1996 and 2001, suggesting that specialization has not been at the expense of waiting times. The use of investigative and diagnostic techniques has increased in line with the recommendations of Campbell and the published evidence advocating triple assessment, 16 ultrasound 17 and core biopsy. 18 Also, despite increased investigations there has been a reduction in delay between patients first being seen at hospital and having their diagnosis established, due in large to the establishment of one-stop breast clinics. Evidence has shown that limited nodal sampling runs the risk of failure to accurately stage the patient and failure to maintain local control in the axilla. 19 Tumour size and the extent of axillary lymph node involvement are the two most important prognostic factors for breast cancer. 20 Our findings showed a significant increase in the number of nodes sampled which suggests a move towards more thorough investigation of the breast cancer patients. This should mean that more patients would be given appropriate treatment.
Evidence of the importance of determining ER status in breast cancer patients has existed for about 30 years, 21 but its use in routine clinical practice was limited by factors such as reliability and cost. This study demonstrates significantly increased recording of ER status and appropriate prescribing of hormone therapy between the two years but this increase may be largely due to an emerging technology rather than because of policy recommendations. Evidence available in 1995 suggested that lumpectomy/wide local excision (followed by irradiation) was the treatment of choice for small tumours and when a mastectomy was indicated, breast reconstruction should be offered. 22 Despite this, mastectomy was the most common mode of surgical treatment in both years in this study and increased between 1996 and 2001. There are several reasons why mastectomy is appropriate even in patients with a small tumour, e.g. tumour behind nipple, patients choice, family history, Paget's disease, relatively small tumour but small breast. Even though mastectomy was the most common procedure in 2001, results show that a greater percentage was performed on women over 75 years old in 2001 compared to 1996.
One of the problems faced by GPs caring for seriously ill patients in the community was a lack of timely information 9 and although letters from hospitals to GPs covered clinical topics well, more should include information relating to the social aspects of the patients disease. 23 Information on whether the patient and/or family were aware of the diagnosis was recorded more frequently in 2001. The time frames of the letter to the GP were not examined. A letter which arrives after the patient has been to see the GP is less useful than one that arrives promptly at discharge. The increased information to the GP will allow better follow-up care for the patient and even protect the patient if they do not wish to know their diagnosis or prognosis. The Campbell Report stated that people with cancer have the right to at least two home visits by an appropriate health professional and information on local support services. 9 This study showed that there was increased information on support groups and designated follow-up care with breast care nurse and/or community nurses in 2001 in line with this recommendation. These changes probably reflect the availability of these services, however, increased availability of these services was recommended in the Campbell report Overall, there have been changes in the provision of breast cancer services in Northern Ireland, which, in general, has been in the direction of the recommendations made in the Campbell report. The ideal service model as described in the Campbell report would have been that all patients received the highest level of care, e.g. all patients would have been discussed in a multidisciplinary setting and all patients would be managed by breast specialists, in 2001 the ideal model was not achieved but the changes described in this paper (Table 1) illustrates that service is moving in the direction intended. It is difficult to directly attribute these changes to the Campbell Report, the breast screening service, which was introduced in 1989 and established in all regions throughout Northern Ireland by 1993 played a vital role through enhanced diagnosis, the BASO guidelines 11 also influenced clinical practice, the Calman-Hine report 8 produced in England and Wales would have influenced clinical practice in Northern Ireland as well as public expectation for better services but the Campbell Report undoubtedly acted as a catalyst to the changes demonstrated in this paper. Further work is required to investigate whether changes in outcomes, e.g. survival has occurred in parallel with the service changes.
What is already known on this topic
Surgeon specialization and multidisciplinary team working are related to measures of effectiveness including, the quality of clinical care and survival.
There is lack of evidence on the effect of breast cancer service reorganization on the processes of cancer care.
What this study adds
A policy change can effect indicators of quality of care including specialization, multidisciplinary team working and communication with primary care.
